Some of the clinical studies also seem to support the positive role of Cav-1 in tumor-induced angiogenesis (in particular studies showing a positive correlation between Cav-1 expressions), tumor microvascular density, and often shorter survival time. The gene discussed is CAV1; the disease is neoplasm.